Vascular endothelial growth factor-d modulates caliber and function of initial lymphatics in the dermis

Journal of Investigative Dermatology

Volumn 133, Issue 8, 2013, Pages 2074-2084

  Paquet Fifield, Sophie ^a,b   Levy, Sidney M ^a,b,c   Sato, Teruhiko ^b,d   Shayan, Ramin ^a,b,c   Karnezis, Tara ^a,b   Davydova, Natalia ^a,b   Nowell, Cameron J ^b   Roufail, Sally ^a,b   Ma, Gerry Zhi Ming ^b   Zhang, You Fang ^a,b   Stacker, Steven A ^a,b,c   Achen, Marc G ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; VASCULOTROPIN D;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DERMIS; GRANULATION TISSUE; LYMPH VESSEL; LYMPHATIC DRAINAGE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; WOUND HEALING;

EID: 84880333521     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.83     Document Type: Article

References (64)

1. Achen MG, Jeltsch M, Kukk E et al. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 95: 548-53 (Pubitemid 28083780)
2. Achen MG, Mann GB, Stacker SA (2006) Targeting lymphangiogenesis to prevent tumour metastasis. Br J Cancer 94:1355-60 (Pubitemid 43772266)
3. Achen MG, McColl BK, Stacker SA (2005) Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 7:121-7 (Pubitemid 40248338)
4. Achen MG, Roufail S, Domagala T et al. (2000) Monoclonal antibodies to vascular endothelial growth factor-D block interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem 267:2505-15 (Pubitemid 30304244)
5. Achen MG, Stacker SA (2008) Molecular control of lymphatic metastasis. Ann NY Acad Sci 1131:225-34 (Pubitemid 351758517)
6. Achen MG, Williams RA, Minekus MP et al. (2001) Localization of vascular endothelial growth factor-D in malignant melanoma suggests a role in tumour angiogenesis. J Pathol 193:147-54 (Pubitemid 32118124)
7. Alitalo K (2011) The lymphatic vasculature in disease. Nature Med 17:1371-80
8. Baldwin ME, Catimel B, Nice EC et al. (2001a) The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man. J Biol Chem 276:19166-71
9. Baldwin ME, Halford MM, Roufail S et al. (2005) Vascular endothelial growth factor d is dispensable for development of the lymphatic system. Mol Cell Biol 25:2441-9 (Pubitemid 40354637)
10. Baldwin ME, Roufail S, Halford MM et al. (2001b) Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis. J Biol Chem 276:44307-14
11. Baldwin ME, Stacker SA, Achen MG (2002) Molecular control of lymphangiogenesis. Bioessays 24:1030-40 (Pubitemid 35326161)
12. Benedito R, Rocha SF, Woeste M et al. (2012) Notch-dependent VEGFR3 upregulation allows angiogenesis without VEGF-VEGFR2 signalling. Nature 484:110-4
13. Bhardwaj S, Roy H, Gruchala M et al. (2003) Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum Gene Ther 14:1451-562
14. Breslin JW, Gaudreault N, Watson KD et al. (2007) Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. Am J Physiol 293:H709-18 (Pubitemid 47105133)
15. Byzova TV, Goldman CK, Jankau J et al. (2002) Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99:4434-42 (Pubitemid 34627212)
16. Cueni LN, Detmar M (2008) The lymphatic system in health and disease. Lymphat Res Biol 6:109-22
17. Debinski W, Slagle-Webb B, Achen MG et al. (2001) VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme. Mol Med 7:598-608 (Pubitemid 34175288)
18. Francois M, Caprini A, Hosking B et al. (2008) Sox18 induces development of the lymphatic vasculature in mice. Nature 456:643-7
19. Grinnell F (1994) Fibroblasts, myofibroblasts, and wound contraction. J Cell Biol 124:401-4 (Pubitemid 24064453)
20. Haiko P, Makinen T, Keskitalo S et al. (2008) Deletion of vascular endothelial growth factor C (VEGF-C) and VEGF-D is not equivalent to VEGF receptor 3 deletion in mouse embryos. Mol Cell Biol 28:4843-50
21. Harris NC, Paavonen K, Davydova N et al. (2011) Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer. FASEB J 25:2615-25
22. Huggenberger R, Siddiqui SS, Brander D et al. (2011) An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117:4667-78
23. Huggenberger R, Ullmann S, Proulx ST et al. (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 207:2255-69
24. James DW, Newcombe JF (1961) Granulation tissue resorption during free and limited contraction of skin wounds. J Anat 95:247-55
25. Jenkins NA, Woollatt E, Crawford J et al. (1997) Mapping of the gene for vascular endothelial growth factor-D in mouse and man to the X chromosome. Chromosome Res 5:502-5 (Pubitemid 27503575)
26. Joukov V, Pajusola K, Kaipainen A et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-8 (Pubitemid 26029207)
27. Kajiya K, Sawane M, Huggenberger R et al. (2009) Activation of the VEGFR-3 pathway by VEGF-C attenuates UVB-induced edema formation and skin inflammation by promoting lymphangiogenesis. J Invest Dermatol 129:1292-8
28. Karkkainen MJ, Haiko P, Sainio K et al. (2004) Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80 (Pubitemid 38081471)
29. Karnezis T, Shayan R, Caesar C et al. (2012) VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell 21:181-95
30. Karpanen T, Heckman CA, Keskitalo S et al. (2006a) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20:1462-72 (Pubitemid 44943854)
31. Karpanen T, Wirzenius M, Makinen T et al. (2006b) Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169:708-18 (Pubitemid 44156326)
32. Koch M, Dettori D, Van Nuffelen A et al. (2009) VEGF-D deficiency in mice does not affect embryonic or postnatal lymphangiogenesis but reduces lymphatic metastasis. J Pathol 219:356-64
33. Kopfstein L, Veikkola T, Djonov VG et al. (2007) Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol 170:1348-61 (Pubitemid 47339341)
34. Lymboussaki A, Partanen TA, Olofsson B et al. (1998) Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am J Pathol 153:395-403 (Pubitemid 28373651)
35. Makinen T, Veikkola T, Mustjoki S et al. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 20:4762-73 (Pubitemid 32848629)
36. Mandriota SJ, Jussila L, Jeltsch M et al. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-82 (Pubitemid 32167632)
37. Marconcini L, Marchio S, Morbidelli L et al. (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci USA 96:9671-6 (Pubitemid 29398790)
38. Martinez-Corral I, Olmeda D, Dieguez-Hurtado R et al. (2012) In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis. Proc Natl Acad Sci USA 109:6223-8
39. Maruyama K, Asai J, Ii M et al. (2007) Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 170:1178-91 (Pubitemid 47339326)
40. McColl BK, Baldwin ME, Roufail S et al. (2003) Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D. J Exp Med 198:863-8 (Pubitemid 37152923)
41. McColl BK, Paavonen K, Karnezis T et al. (2007) Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2. FASEB J 21:1088-98 (Pubitemid 46495698)
42. Ny A, Koch M, Vandevelde W et al. (2008) Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 112:1740-9
43. Oliver G, Alitalo K (2005) The lymphatic vasculature: recent progress and paradigms. Annu Rev Cell Dev Biol 21:457-83 (Pubitemid 41740643)
44. Paavonen K, Puolakkainen P, Jussila L et al. (2000) Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol 156:1499-504 (Pubitemid 30646689)
45. Partanen TA, Arola J, Saaristo A et al. (2000) VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J 14:2087-96
46. Pennisi D, Bowles J, Nagy A et al. (2000) Mice null for sox18 are viable and display a mild coat defect. Mol Cell Biol 20:9331-6 (Pubitemid 32246117)
47. Rissanen TT, Markkanen JE, Gruchala M et al. (2003) VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 92:1098-106 (Pubitemid 36665855)
48. Rutanen J, Leppanen P, Tuomisto TT et al. (2003) Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc Res 59:971-9 (Pubitemid 38366253)
49. Rutanen J, Rissanen TT, Markkanen JE et al. (2004) Adenoviral cathetermediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation 109:1029-35 (Pubitemid 38282857)
50. Shayan R, Achen MG, Stacker SA (2006) Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27:1729-38 (Pubitemid 44307827)
51. Shayan R, Karnezis T, Tsantikos E et al. (2007) A system for quantifying the patterning of the lymphatic vasculature. Growth Factors 25:417-25 (Pubitemid 351455007)
52. Shimamura K, Nakatani T, Ueda A et al. (2009) Relationship between lymphangiogenesis and exudates during the wound-healing process of mouse skin full-thickness wound. Wound Repair Regen 17:598-605
53. Skobe M, Hawighorst T, Jackson DG et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-8 (Pubitemid 32148486)
54. Stacker SA, Caesar C, Baldwin ME et al. (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-91 (Pubitemid 32148485)
55. Stacker SA, Stenvers K, Caesar C et al. (1999) Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 274:32127-36
56. Stacker SA, Williams RA, Achen MG (2004) Lymphangiogenic growth factors as markers of tumor metastasis. APMIS 112:539-49 (Pubitemid 39626059)
57. Tabibiazar R, Cheung L, Han J et al. (2006) Inflammatory manifestations of experimental lymphatic insufficiency. PLOS Med 3:e254
58. Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140:460-76
59. Tammela T, Zarkada G, Nurmi H et al. (2011) VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol 13:1202-13
60. Tammela T, Zarkada G, Wallgard E et al. (2008) Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 454: 656-60
61. Veikkola T, Jussila L, Makinen T et al. (2001) Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 20:1223-31 (Pubitemid 32233963)
62. Vlahakis NE, Young BA, Atakilit A et al. (2005) The lymphangiogenic vascular endothelial growth factors VEGF-C and-D are ligands for the integrin alpha9beta1. J Biol Chem 280:4544-52 (Pubitemid 40288622)
63. Von Marschall Z, Scholz A, Stacker SA et al. (2005) Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 27:669-79
64. Wise LM, Ueda N, Dryden NH et al. (2003) Viral vascular endothelial growth factors vary extensively in amino acid sequence, receptor-binding specificities, and the ability to induce vascular permeability yet are uniformly active mitogens. J Biol Chem 278:38004-14 (Pubitemid 37175331)